Applied Genetic Technologies Corporation

NasdaqGM:AGTC Rapport sur les actions

Capitalisation boursière : US$12.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Applied Genetic Technologies Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

92.6%

Ratio d'endettement

US$16.34m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$34.24m
Fonds propresUS$17.65m
Total du passifUS$39.69m
Total des actifsUS$57.33m

Mises à jour récentes de la santé financière

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Recent updates

AGTC receives positive feedback from FDA for manufacturing facility

Jul 26

Applied Genetic Technologies proposes stock offering to fund clinical trials

Jul 12

Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022

Jan 12

An Assessment Of Applied Genetic Technologies Corporation

Dec 14

Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk

Jul 15

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Applied Genetic trades lower after announcing the departure of chief scientific officer

Apr 26

What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Feb 05
What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 11
What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic

Nov 11

Analyse de la situation financière

Passif à court terme: AGTC's short term assets ($37.2M) exceed its short term liabilities ($26.6M).

Passif à long terme: AGTC's short term assets ($37.2M) exceed its long term liabilities ($13.1M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: AGTC has more cash than its total debt.

Réduire la dette: Insufficient data to determine if AGTC's debt to equity ratio has reduced over the past 5 years.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: AGTC has less than a year of cash runway based on its current free cash flow.

Prévisions de trésorerie: AGTC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year


Découvrir des entreprises saines